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INTRODUCTION 
 
 Coronary heart disease is the leading cause of death in Western 
countries and it is now an increasing problem in developing countries 
too, due to changes in life style and dietary habits. 
 
 Heart Disease is responsible for more deaths and disability 
among Western Population, both male and female, than any other 
killer disease, and it is quickly establishing itself as the leading cause 
of death and disability among Indians as well. 
 
 This sudden increase in incidence of Heart disease is seen in our 
people, as they have adopted a more sedentary westernized life style, 
together with the intake of high-fat, high-salt diet and processed foods 
that have come to be associated with technological affluence. 
Researchers are noticing that Diseases prevalent in western 
hemisphere are now becoming more and more the prevalent causes of 
death in Asia. 
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 The most important cause of Coronary Artery Disease is 
‘Atherosclerosis’. 
 The risk factors for atherosclerosis are, 
1. Smoking 
2. Diabetes mellitus 
3. Dyslipidemia 
4. Sedentary life style 
5. Positive family history 
6. Hypertension 
7. Obesity 
 
 The association between atherosclerotic diseases and elevated 
fasting plasma LDL-C and reduced fasting plasma HDL-C is well 
established. 
 
 However, many individuals without fasting lipid abnormalities 
develop atherosclerotic diseases and several lines of evidence suggest 
that nonfasting lipid measurements may be more relevant to 
artherogenesis.  
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 Typical diets are associated with measurable postprandial 
lipemia 18 hours per day. A major source of circulating triglycerides is 
dietaryfat, which after hydrolysis into free fattyacids and glycerides, is 
transported through the intestinal villi and absorbed by enterocytes 
where these particles are synthesised into chylomicron - associated 
Triglycerides for entry into the blood compartment and ultimately 
storage in adipose tissue. 
 
 Postprandial lipids and their associated partially hydrolysed 
chylomicron remnants appear to promote early atherogenesis and  
adversely affect endothelial function, associate with atherogenic small 
LDL particles, and correlate with both pro-thrombotic and 
proinflammatory biomarkers, including factor VII, plasminogen 
activator inhibitor-1,. and C-reactive protein. Thus measurement of 
postprandial Triglycerides - particularly because they peak 3-4hr after 
ingestion of a fat-rich meal-might well provide more relevant 
information on vascular risk than measurements based on fasting 
concentrations. 
 
 Diabetic patients have delayed clearance of Triglyceride from 
blood. Most type 2 diabetic patients have postprandial triglycerides 
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above optimal concentrations for several hours after meals. Moreover, 
optimal fasting concentrations are not always a good predictor of 
postprandial triglycerides.  
 
 So there should be some association of postprandial lipid 
Metabolism and atherosclerosis, which remains to be proved. 
 
 Two articles recently published in the  Journal of the American 
Medical Association directly address these issues by comparing 
fasting with nonfasting (Postprandial) triglycerides with respect to the 
prediction of future cardiovascular events. 
 
 The first report derived from the Women’s Health study cohort 
showed nonfasting triglycerides maintained a strong independent 
relationship with future cardiovascular events in fully adjusted 
analyses. 
 
 The second report derived from a prospective cohort study 
showed nonfasting triglycerides were also found to significantly 
predict future vascular events in both sexes after multivariate analysis. 
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 These data not only derive from typical western populations in 
the US and Europe but also extend to otherwise low risk populations 
in which overt hyperlipidemia is less prevalent. 
 
 In an Asia Pacific cohort studies collaboration study that 
included date from 26 cohorts, postprandial triglyceride concentrations 
were a more potent predictor of incident vascular events than were 
fasting triglycerides. 
 
 Our study is aimed at establishing the association between 
postprandial hypertriglyceridemia and atherosclerosis. 
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AIMS AND OBJECTIVES 
 
¾ To study relation between risk factors for atherosclerosis and 
fasting and postprandial triglyceride levels in patients of 
unstable angina. 
 
¾ To establish that post-prandial triglycerides level is a better 
indicator as a ‘risk factor’ for atherosclerosis. 
 
¾ To study risk factors for atherosclerosis in diabetic and non-
diabetic patients having normal fasting triglyceride. 
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LIMITATIONS OF THE STUDY 
 
¾ The sample size should be large for avoiding the significant 
difference of disparity between group of patients, with large 
sample size there would be near equal distribution in each 
group. 
 
¾ The cut off value of normal postprandial triglyceride is not yet 
internationally standardized. We had chosen the value, less than 
160mg% as “Normal postprandial” triglyceride levels. Many 
authorities suggest that it should be less than 170mg%.  
 
¾ The fat proportion of the diet on day the of collecting blood for 
postprandial triglyceride level assessment needs to be 
formulated. 
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MATERIALS AND METHODS 
 
MATERIALS: 
1. SELECTION OF PATIENTS: 
 This study was carried out in reference to 100 patients, 
diagnosed to have ischemic heart disease who were admitted at Govt. 
Mohan Kumramangalam Medical College  Hospital, Salem  for 
unstable angina.  The study was approved by the Department of 
medicine. 
 This study was conducted on patients between January 2007 
and June 2008. 
 
2. INCLUSION CRITERIA: 
1.  Unstable angina diagnosed on classical anginal chest pain or 
anginal chest pain equivalent 
With 
 ECG showing ST segment depression in two consecutive chest 
leads or Limb leads and Normal S.CPK-MB levels. 
 
2. Fasting S. Triglycerides <150 mg% 
3. Fasting S. Cholesterol < 180 mg% 
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3. EXCLUSION CRITERIA: 
1.  Patient on treatment with Tablet Rosiglitazone in past one 
 month. 
2.  On treatment with lipid lowering drugs. 
3. Suspected cases of Prinzmetal’s angina 
4.  Rheumatic heart disease 
5. Oral contraceptive pills or other hormone therapy 
6. Abnormal liver and Renal function test. 
 
METHODS: 
1. HISTORY 
 A complete and detailed history of patient with address, 
occupation, past history of diabetes, hypertension, family history, 
habits of smoking and alcohol was noted. 
 
2. CLINICAL ASSESSMENT 
• A complete physical and cardiovascular system examination 
performed. 
• Blood pressure measurements were performed with mercury 
sphygmomanometer in a standardized fashion. 
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• Height measured in standing position without shoes with a 
standard tape meter. 
• Body mass index was calculated with formula of B.M.I = 
wt(kg) /Ht (m2) 
 
 Classification of obesity was done as per the National Institutes 
of Health Definition: 
Normal range: 18.5-24.9 
Over weight: 25-29.9 
Obesity: 
 Class I - 30-34.9 
 Class II - 35- 39.9 
 Class III - > 40 
 Waist circumference was measured at umbilical level. Hip 
circumference was measured at maximum girth at hip.  
 
 Waist hip ratio cut off points > 1.0 for male and > 0.85 for 
female was considered. 
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3. EGG: 
 Recording of ECG  was done with 12 leads recording in 
standard fashion with B.P.L machine. 
 
4. BIOCHEMICAL ASSESSMENTS 
¾ Fasting samples of blood glucose, 
¾ Fasting Lipid profile was measured which includes 
measurements of 
 S.Cholesterol, 
 S.tryglyceride, 
 HDL, 
 LDL 
 VLDL. 
 Post prandial 2 hr glucose 
 4hr blood samples for triglycerides levels. 
 
5.      PREREQUISITE FOR BIOCHEMICAL INVESTIGATION 
1. Fasting lipid profile defined as at least 12 hour fast overnight 
in which only water is permitted. 
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2. Fasting blood sample collected in pre-sterile plain and pre-
sterile sugar bulbs for fasting lipid profile and fasting blood 
glucose. 
3. After which the patient is allowed to take routine breakfast. 
4. Patients are not allowed to take Chocolate, ice cream on the 
day of investigation. 
5. Patients asked to take routine standard meal in their lunch 
and after four hour of lunch, blood sample was collected for 
measurement of S. triglycerides. 
 
6. DEFINITIONS 
 1. Normal Fasting Triglycerides < 150 mg% 
 2. Normal Post-prandial Triglycerides < 160 mg% 
 3. Criteria for Diagnosis of Diabetes Mellitus made if one of  
  the following is present, 
a. Symptoms of diabetes plus random blood glucose 
concentration ≥11.1 mmol/L (200 mg/dL) 
b. Fasting plasma glucose ≥ 7.0 mmol/L (126 mg/dL) 
c. Two-hour plasma glucose ≥ 11.1 mmol/L (200 
mg/dL) during an oral glucose tolerance test. 
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 Enzymatic methods were used on fresh samples to measure 
Plasma levels of nonfasting triglycerides (postprandial triglycerides), 
total cholesterol and high density lipoprotein (HDL) Cholesterol. Low 
density Cholesterol was calculated by using the Friedewald formula. 
 
7. DATA ANALYSIS 
 Data analysis done in order of: 
A. Profile of Patients 
B. Segregation of patients into two groups according to  
 1. Postprandial Triglyceride levels 
  Normal : up to 160 mg% 
  High  : > 160 mg% 
 2. According to presence or absence of Diabetes Mellitus 
 3. Obese and non-obese. 
 4. According to Waist-Hip ratio, 
 
C. Statistical analysis was performed and data analyzed in form of 
calculation of Mean and standard deviation. Calculation and analysis 
of variance and t-test were used to test statistically significant 
differences in groups. The significance of test was decided on the 
basis of P-value. Two tailed P-values < 0.05 were considered 
significant, chi-square test was applied to test the relationship of two 
attributes. 
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1. ATHEROSCLEROSIS 
 
Atherosclerosis is the leading cause of death and disability in 
the developed world. Despite our familiarity with this disease, some 
of its fundamental characteristics remain poorly, recognized and 
understood. Although many generalized or systemic risk factors 
predispose to its development, atherosclerosis affects, various regions 
of the circulation preferentially and yields distinct clinical 
manifestations depending on the particular circulatory bed affected. 
 
DEFINITION 
Atherosclerosis is disease .of large and medium sized arteries 
and characterized by endothelial dysfunction, vascular inflammation, 
and build of lipids, cholesterol, calcium, cellular debris within intima 
of vessel wall. 
 
This build up results in plaque formation, vascular remodeling, 
acute and chronic luminal obstruction, abnormalities of blood flow 
and diminished supply of oxygen to tissue. 
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PATHOGENESIS AND HISTOLOGY 
The initial lesion in atherosclerosis involves the intima of the 
artery and begins in childhood with the development of fatty streaks.  
 
Early arterial accumulation of cholesterol causes a reduction in 
arterial distensibility, which occurs before other vessel wall changes 
become apparent; the loss of distensibility, which increases with age, 
is related to development of atherosclerosis. A loss of vessel 
distensibility also occurs with accumulation of cholesterol in the 
vessel wall, even in young subjects. 
 
Fatty Streaks – The first phase in atherosclerosis histologically 
presents as focal thickening of the intima with an increase in smooth 
muscle cells and extracellular matrix. These smooth muscle cells, 
which are possibly derived from hematopoietic stem cells, migrate and 
proliferate within the intima. This is followed by accumulation of 
intracellular lipid deposits or extracellular lipids or both, which 
produce the fatty streak. Biglycan, a small dermatan sulfate 
proteoglycan, can be detected in the intima of atherosclerotic 
‘coronary’ artery segments; it can bind and trap lipoproteins, including 
apolipoprotein E, VLDL remnants, LDL, and HDL. The fatty streak 
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also consists of macrophages with a variable number of T 
lymphocytes. 
 
As these lesions expand, more smooth muscle cells migrate into 
the intima. The smooth muscle cells within the deep layer of the fatty 
streak are susceptible to apoptosis which is associated with further 
macrophage infiltration and cytoplasmic remnants that can calcify, 
perhaps contributing to the transition of fatty streaks into 
atherosclerotic plaques. 
 
Fibrous plaque - The fibrous plaque evolves from the fatty 
streak via accumulation of connective tissue with an increased number 
of smooth muscle cells ladened with lipids and often a deeper 
extracellular lipid pool. 
 
Advanced lesions - More advanced lesions become 
revascularized from both the luminal and medial aspects, and often 
contain a necrotic lipid rich core, which can eventually become 
calcified. 
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Advanced lesions are associated with coronary artery 
remodeling. Positive remodeling is· defined as a positive correlation 
between plaque and external elastic membrane area due to a 
compensatory increase in local vessel size in response to increasing 
plaque burden (dilated coronary atherosclerosis), while negative 
remodeling refers to a smaller external elastic membrane area at the 
lesion site due to the local shrinkage of vessel size. 
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PATHOGENESIS 
Multiple factors contribute to the pathogenesis of 
atherosclerosis including 
1. Endothelial dysfunction 
2. Dyslipidemia 
3. Inflammatory and immunologic factors 
4. Plaque rupture 
5. Smoking 
6. Infection 
 
ENDOTHELIAL DYSFUNCTION 
 Endothelial dysfunction induced by dyslipidemia is an initial 
step in atherosclerosis. A positive family history aggravates the 
endothelial dysfunction associated with hypercholesterolemia and age, 
suggesting additive effects of genetic and environmental risk factors. 
 
Endothelial dysfunction is induced by oxidized LDL, can be 
worsened by cigarette smoking, and can be reversed with correction of 
hyperlipidemia by diet or by therapy with a statin. 
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LIPID METABOLISM AND DYSLIPIDEMIA 
Lipoproteins are complexes of lipids and proteins that are 
essential for the transport of cholesterol, triglycerides, and fat-soluble 
vitamins. The metabolic consequences associated with changes in diet 
and lifestyle have increased the number of hyperlipidemic individuals, 
and hyperlipidemia and atherosclerosis are strongly associated. 
 
Lipoproteins are large, mostly spherical complexes that 
transport lipids primarily triglycerides, cholesterol, and fat-soluble 
vitamins through body fluids plasma, interstitial fluid, and lymph to 
and from tissues. Lipoproteins play an essential role in the absorption 
of dietary cholesterol, long-chain fatty acids, and fat-soluble vitamins, 
the transport of triglycerides, cholesterol, and fat-soluble vitamins 
from the liver to peripheral tissues, and the transport of cholesterol 
from peripheral tissues to the liver. 
 
TRANSPORT OF DIETARY LIPIDS (EXOGENOUS PATHWAY) 
The endogenous pathway of lipoprotein metabolism permits 
efficient transport of dietary lipids. Dietary triglycerides are 
hydrolyzed by lipases within the intestinal lumen and are emulsified 
with bile acids to form micelles. 
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Dietary cholesterol and retinol are esterified by the addition of a 
fatty acid in the enterocyte to form cholesteryl esters and retinyl esters, 
respectively. Longer-chain fatty acids (>12 carbons) are incorporated 
into triglyceride and packaged with apo B-48, cholesteryl esters, 
retinyl esters, phospholipids, and cholesterol to form chylomicrons. 
 
Nascent chylomicrons are secreted into the intestinal lymph and 
delivered via the thoracicduct directly to the systemic circulation, 
where they are extensively processed by peripheral tissues before 
reaching the liver. The particles encounter lipoprotein lipase (LPL), 
which is anchored to proteoglycans that decorate the capillary 
endothelial surfaces of adipose tissue, heart and skeletal muscle. 
 
The triglycerides of chylomicrons are hydrolyzed by LPL, and 
free fatty acids are released. ApoC-II, which is transferred to 
circulating chylomicrons, acts as a cofactor for LPL in this reaction. 
The released free fatty acids are taken up by adjacent myocytes or 
adipocytes and either oxidized or reesterified and stored as 
triglyceride. Some free fatty acids bind albumin and are transported to 
other tissues, especially the liver. The chylomicron particle 
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progressively shrinks in size as the hydrophobic core is hydrolyzed 
and the hydrophilic lipids (cholesterol and phospholipids) on the 
particle surface are transferred to HDL. The resultant smaller, more 
cholesterol ester-rich particles are referred to as chylomicron 
remnants. The remnant particles are rapidly removed from the 
circulation by the liver in a process that, requires apoE. 
 
TRANSPORT OF HEPATIC LIPIDS  
(ENDOGENOUS PATHWAY) 
The endogenous pathway of lipoprotein metabolism refers to 
the hepatic secretion and metabolism of VLDL to IDL and LDL. 
VLDL particles resemble chylomicrons in protein composition but 
contain apoB-100 rather than apoB-48 and have a higher ratio of 
cholesterol to triglyceride. 
 
The triglycerides of VLDL are derived predominantly from the 
esterification of long-chain fatty acids. The packaging of hepatic 
triglycerides with the other major components of the nascent VLDL 
particle (apoB-100, cholesteryl esters, phospholipids, and vitamin E) 
requires the action of the enzyme microsomal Triglyceride transfer 
protein (MTP). 
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After secretion into the plasma, VLDL acquires multiple  copies 
of apoE and apolipoproteins of the C series. The triglycerides of 
VLDL are hydrolyzed by LPL, especially in muscle and adipose 
tissue. As VLDL remnants undergo further hydrolysis, they continue 
to shrink in size and become IDL, which contain similar amounts of 
cholesterol and triglyceride. 
 
The liver removes approximately 40 to 60% of VLDL remnants 
and IDL by LDL receptor-mediated endocytosis via binding to apoE. 
The remainder of lDL is remodeled by hepatic lipase (HL) to form 
LDL. During this process, most of the triglyceride in the particle is 
hydrolyzed, and all apolipoproteins except apoB-100 are transferred to 
other lipoproteins. 
 
The cholesterol in LDL accounts for overhalf of the plasma 
cholesterol in most individuals. Approximatedly 80% of circulating 
LDL is cleared by LDL receptor-mediated endocytosis in the liver. 
Lipoprotein(a) [Lp(a)] is a lipoprotein similar to LDL in lipid and 
protein composition, but it contains an additional protein called 
apolipoprotein(a) [apo(a)]. Apo(a) is synthesized in the liver and is 
attached to apoB-100 by disulfide linkage. The major site of clearance 
of Lp(a) is the liver, but the uptake pathway is not known. 
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HDL METABOLISM AND REVERSE CHOLESTEROL 
TRANSPORT 
All nucleated cells synthesize cholesterol, but only hepatocytes 
and enterocytes can effectively excrete cholesterol from the body. The 
predominant route of cholesterol elimination is by excretion into the 
bile, either directly or after conversion to bile acids. Cholesterol in 
peripheral cells is transported from the plasma membranes of 
peripheral cells to the liver and intestine by an HDL-mediated process 
termed “reverse cholesterol” transport. 
 
DYSLIPIDEMIA  
Lipid abnormalities play a critical role in the development of 
atherosclerosis. High levels of low density lipoprotein (LDL) and low 
levels of high density lipoprotein (HDL) are particularly important 
risk factors for atherosclerosis. 
 
Circulating LDL rapidly accumulates in the cholesterol-
enriched macrophages (called foam cells), but not the lipid core, of 
atherosclerotic plaque. Oxidative modification of LDL is a 
prerequisite for macrophage via unregulated scavenger receptors and 
accelerated accumulation of cholesterol. Macrophage uptake of LDL 
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cholesterol may initially be an adaptive response, which prevents 
LDL-induced endothelial injury. However, cholesterol accumulation 
in foam cells leads to mitochondrial dysfunction, apoptosis, and 
necrosis, with resultant release of cellular proteases, inflammatory 
cytokines, and prothrombotic molecules. 
 
Oxidized LDL can cause disruption of the endothelial cell 
surface, promote inflammatory and immune changes via cytokine 
release from macrophages and antibody production, and increase 
platelet aggregation. It may also play a role in plaque instability. 
Levels of oxidized LDL are increased in patients with an acute 
coronary syndrome and are positively correlated with the severity of 
the syndrome. HDL, in contrast to LDL, has antiatherogenic properties 
that include reverse cholesterol transport, maintenance of endothelial 
function, protection against thrombosis, and maintenance of low blood 
viscosity through a permissive action on red cell deformability.  
 
Several large prospective observational studies and intervention 
trials show a strong positive relationship between raised TGL and 
CAD – a dose response relationship. Hypertriglyceridemia is an 
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independent risk factor for coronary artery disease when it is 
associated with low HDL and/or raised LDL. 
 
There is an inverse relation between HDL and CAD. The 
mechanism by which HDL confers decreased risk of CAD is poorly 
understood.  
 
1. They indirectly initiate TGL catabolism and remnant 
removal. 
2. They accept free cholesterol from cells and play a key 
role in cholesterol transport. 
 
 Lipoprotein (a) [LP (a)] is an independent risk factor for CAD. 
The level of LP (a) is genetically determined, occurs as a complex 
between LDL and plasma apolipoprotein (a). It is ten times more 
atherogenic than LDL. Levels > 30 mg/dl is associated with CAD risk. 
 
PLAQUE HAEMORRHAGE 
As atherosclerotic plaques develop and expand, they acquire 
their own microvascular network (vasa vasorum) extending from the 
adventitia through the media and into the thickened intima. These 
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thin-walled vessels are prone to disruption, leading to haemorrhage 
within the substance of the plaque. 
 
PLAQUE RUPTURE 
Atherosclerosis is generally asymptomatic until the plaque 
stenosis exceeds 70 or 80 percent, which can produce a. critical 
reduction in flow, as with. coronary blood flow to myocardium. These 
large lesions can produce typical symptoms of angina pectoris. 
However, acute coronary and cerebrovascular syndromes (unstable 
angina, myocardial infarction, sudden death, and stroke) are typically 
due to rupture of plaques with less than 50 percent stenosis. Plaque 
rupture may also be silent; repeated silent ruptures and thrombosis, 
followed by wound healing, may cause progression of atherosclerosis, 
with an increase in plaque burden and percent stenosis and negative 
arterial remodeling.  
 
INFECTION 
Chronic infection may contribute to the pathogenesis of 
atherosclerosis. The major organisms that have been studied are 
Chlamydia pneumoniae, cytomegalovirus (CMV), and Helicobacter 
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pylori; however, hepatitis A virus (HAV) and herpes simplex virus 
(HSV) type 1 and type 2 have also been implicated. 
 
DIABETIC DYSLIPIDEMIA 
Alteration of lipid metabolism in Diabetics:  
1. Hypertriglyceridemia 
2. Decreased HDL cholesterol 
3. Decreased HDL2/HDL3 ratio 
4. Decreased lipoprotein lipase activity 
5. Increased hepatic triglyceride activity 
6. Prolonged postprandial lipemia 
7. increased lipoprotein (a) in presence of diabetic 
nephropathy 
 
 Hypertriglyceridemia is associated with Insulin resistance and 
Type 2 Diabetes Mellitus. There is good correlation between insulin 
resistance and plasma TGL concentration, has TGL may influence an 
early step in the insulin action pathway. Alternatively insulin 
resistance may cause Hypertriglyceridemia. A contributory factor to 
Hypertriglyceridemia in type 2 diabetes is the inability of insulin to 
inhibit acutely the release of VLDL from the liver, despite the efficient 
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suppression of non-esterified fatty acids impairment in VLDL and 
chylomicron removal due to decreased Lipoprotein lipase activity in 
the adipose tissue also occurs in diabetic subjects. The volume of 
VLDL particles is of major importance in Atherogenicity by 
determining the size and cholesterol content of the LDL formed. Large 
VLDL particles with High TGL content are the precursors of small 
dense LDL, which determine the severity of Atherosclerosis. The 
association of low HDL with Hypertriglyceridemia is due to the fact 
that TGL – enriched HDL – Cholesterol is hydrolysed by Hepatic 
lipase and small dense HDL particles are formed, which are cleared 
from circulation, leading to low serum levels of HDL cholesterol. 
 
METABOLIC SYNDROME 
The Metabolic syndrome, as defined by the NCEP, is not to be 
confused with the insulin resistance syndrome although such 
resistance is likely but not always in patients with metabolic 
syndrome. Based on the criteria of the NCEP, the diagnosis of 
metabolic syndrome is highly effective in predicting excess 
cardiovascular risk. 
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National Cholestrol Education Program, Adult Treatment Panel 
III (NCEP : ATP III) 2001 criteria for the Metabolic Syndrome.  
 
Three or more of the following. 
¾ Central Obesity: Waist Circumference > 102 cm (M), >88 cm 
(F). 
¾ Hypertirglyceridemia : Triglycerides ≥ 150 mg/dL. (or) Specific 
Medication. 
¾ Low HDL Cholestrol : < 40 mg/dL and < 50 mg/dL, 
respectively, (or) specific Medication. 
¾ Hypertension : Blood Pressure ≥ 130 mmHg Systolic (or) ≥ 85 
mmHg diastolic (or) Specific Medication. 
¾ Fasting Plasma Glucose : ≥ 100 mg/dL (or) Specific Medication 
(or) Previously diagnosed type 2 Diabetes. 
 
International Diabetes Foundation (IDF) criteria for Central 
Adiposity. 
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WAIST CIRCUMFERENCE 
Men Women Ethnicity 
≥ 94 cm ≥ 80 cm Europid, Sub-Saharan African, Eastern & Middle Eastern 
≥ 90 cm ≥ 80 cm South Asian, Chinese, South & Central American 
≥ 85 cm ≥ 90 cm Japanese 
 
Two or more of the following: 
¾ Fasting Triglycerides > 150 mg/dL (or) Specific Medication. 
¾ HDL Cholestrol < 40 mg/dL and < 50 mg/dL for men and 
women, respectively, or Specific Medication. 
¾ Blood Pressure > 130 mmHg Systolic or > 85 mmHg diastolic 
or previous diagnosis or Specific Medication. 
¾ Fasting Plasma glucose ≥ 100 mg/dL or previously diagnosed 
Type 2 diabetes. 
 
POSTPRANDIAL HYPERTRIGLYCERIDEMIA:  
The plasma level of triglyceride varies widely through the day. 
TGL levels are elevated for most of the day even in subjects with 
Normal fasting TGL. The status of fasting TGL as a risk factor for 
coronary artery disease has been considered to be weak because in 
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multi-variate analysis, the effect of TGL tends to be eliminated by a 
low HDL cholesterol level elevated postprandial TGL levels have 
been observed in persons with fasting Hypertriglyceridemia, in 
smokers and there is also growing evidence that elevation of 
postprandial TGL is associated with endothelial dysfunction, and with 
thrombogenic alterations in the coagulation system.  
 
Severe postprandial Hypertriglyceridemia is associated with an 
inflammatory state and enhanced production of TNF-, IL-, and C-
reactive protein.  
 
Postprandial triglyceride levels, which indicate the presence of 
remnant lipoproteins, are associated with increased risk of Ischemic 
heart disease. Most previous studies on triglycerides have focused on 
fasting levels that exclude remnant lipoproteins. 
 
This Postprandial Triglyceride – rich remnant lipoproteins 
penetrate the endothelium and appear to be preferentially trapped 
within the arterial wall. 
The Copenhagen city Heart Study, a prospective cohort study of 
Danish general population, found that nonfasting postprandial 
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Triglyceride levels independently predict Myocardial infarction, 
Ischemic heart disease and death in men and women. 
 
The adverse effect of postprandial triglyceride on endothelial 
dysfunction has been reported in both normal and diabetic patients. 
Both hypertriglyceridemia and hyperglycemia induce endothelial 
dysfunction, Oxidative stress to be common mediator of such effects. 
 
There is over production of superoxide anion, which in turn 
inactivates nitric oxide, produces peroxynitrate, a potent and long 
living nitrating agent. 
 
This peroxynitrate leads to a host of potentially injurious events, 
including VLDL oxidation, depletion of antioxidant defence, and 
inactivation of enzymes. Oxidant can be directly cytotoxic to 
endothelial cell. All these events are involved in pathogenesis of 
atherosclerosis. 
 
The observations demonstrated good relationship between 
postprandial lipemia and atherosclerosis and suggested that 
postprandial triglyceride levels may be better indicator of 
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atherogenesis than fasting TGs levels. Postprandial lipemia can be an 
independent risk factor for atherosclerosis. 
 
However in all trials interval of measuring triglycerides are 
different and some trial used fat load, instead of normal diet. So 
precise guidelines for interval for measuring TGs is yet to be 
formulated and normal cutoff values for postprandial TGs levels are to 
be decided. 
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OBSERVATION AND DATA ANALYSIS 
 
TABLE  - 1 
DISTRIBUTION ACCORDING TO AGE AND SEX 
 
Age Male Female Total 
35-45 6 17 23 
46-55 27 19 46 
56-65 16 5 21 
> 66 7 3 10 
Total 56 44 100 
 
 In the present study there were total 100 patients, out of whom 
56 were male and 44 were female. Only 17 female patients are aged 
less than 46 years. There were 46 patients in age group 46-55, out of 
which 27 were male, and 19 were female. 
 
 In the age group 56-65 years, 16 were male and 5 were female, 
while only 7 male and 3 female were in > 65 years age group.  The 
mean age of 47.10 ± 5.2 years.  
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TABLE  - 2 
DISTRIBUTION ACCORDING TO BODY MASS INDEX AND 
GENDER 
 
BMI Male Female Total 
Normal 5 3 8 
Over weight 25 15 40 
GR – I Obesity 16 19 35 
GR – II Obesity 8 6 14 
GR – III Obesity 2 1 3 
Total 56 44 100 
 
 In our study, 40 patients were over weight, 52 were obese, and 
only 8 patients had normal weight. 25 male (62.5%) were over weight, 
26 male (50%) were obese, 5 male (62.5%) had normal weight. In 44 
females, 15 females (37.5%) were overweight, 26 females (50%) were 
obese, 3 females (37.5%) had normal weight. 
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TABLE  - 3 
DISTRIBUTION OF PATIENTS ACCORDING TO WAIST-HIP 
RATIO AND SEX 
 
W-H Ratio Male Female Total 
Normal 16 11 27 
High 40 33 73 
Total 56 44 100 
 
 In the present study, 40 male patients (71.4%) and 33 female 
patients (75%) had high waist-hip ratio. 
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TABLE  - 4 
PRESENCE OF DIABETES MELLITUS 
 
D.M. Male Female Total 
Presence 34 30 64 
Absence 22 14 36 
Total 56 44 100 
 
 In our study, out of 56 male 34 (62.5%) were suffering from 
diabetes mellitus. While 30 female out of 44 were (68.18%) diabetic. 
So out of 100 patients 64 patients were suffering from diabetes. 
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TABLE  - 5 
PRESENCE OF HYPERTENSION 
 
Hypertension Male Female Total 
Presence 32 25 57 
Absence 24 19 43 
Total 56 44 100 
 
 In our study, 57 patients were hypertensive. 32 male patients 
out of 56 male patients were hypertensive (57.14%) and 25 female 
patients out of 44 patients (56.81%) were hypertensive. 
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TABLE  - 6 
DISTRIBUTION ACCORDING TO PP4TG 
 
PP4TG Male Female Total 
Normal 22 14 36 
High 34 30 64 
Total 56 44 100 
 
 In this study, out of 100 patients, 64 patients showed 
S.triglyceride levels >160 mg% after four hour of meal. 34 out of 56 
male patients (60.7%) and 30 out of 44 female (68.18%) showed post 
prandial hypertrigly ceridemia. 
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TABLE  - 7 
DISTRIBUTION ACCORDING TO F. HDL 
 
HDL Male Female Total 
Low 32 26 58 
Normal 24 18 42 
Total 56 44 100 
 
 In this study, 58 patients had low fasting HDL level (less than 
40 mg% in Male, less than 50 mg% in Female), 36 out of 56 male 
(64.28%) and 22 out of 44 female (50%) had low fasting HDL level. 
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TABLE  - 8 
BASELINE CHARACTERISTICS 
 
Characteristic Mean Std. Errs. 
Age 52.06 0.8 
B.M.I. 30.08 0.5 
W-H Ratio 0.99 0.011 
SBP 135.82 1.66 
DBP 88.59 1.075 
FBS 155.31 3.6 
PP2BS 207.69 5.2 
F.HDL 50.89 0.75 
F.LDL 94.88 1.29 
PP4TG 181.47 2.148 
 
 In this study, out of 100 patients, 64 patients showed 
S.triglyceride levels >160 mg% after four hour of meal. 34 out of 56 
male patients (60.7%) and 30 out of 44 female (68.18%) showed post 
prandial hypertrigly ceridemia. 
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TABLE  - 9 
DISTRIBUTION ACCORDING TO AGE AND PP4TG 
 
Age Normal  PP4TG High PP4TG Total 
35-45 7 16 23 
46-55 15 31 46 
56-65 12 9 21 
> 66 2 8 10 
Total 36 64 100 
 
 In the present study, postprandial hypertriglyceridemia was 
found in 16 patients out of 23 patients (69.5%) in the age group 35-45, 
31 patients out of 46 patients (67.39%) in the age group 46-55, 9 out 
of 21 patients (42.8%) in the age group 56,-65, and 8 patients out of 
10 (80%) in the age > 66 years. 
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TABLE  - 10 
DISTRIBUTION ACCORDING TO WAIST-HIP RATIO AND 
PP4TG 
 
W-H Ratio Normal  PP4TG High PP4TG Total 
Normal 22 2 24 
High 14 62 76 
Total 36 64 100 
 
 In the present study, out of 76 patients having high waist-hip 
ratio, 62 (81.5%) had high postprandial triglyceridemia, while 14 
patients had normal Postprandial triglycerides. Out of 24 patients 
having normal waist-hip ratio, 2 had high postprandial triglyceride 
levels, while 22 had normal postprandial triglyceride levels. 
 
 The calculated P-value was < 0.01, suggesting association 
between High waist-hip ratio and High PP4TG level. 
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TABLE  - 11 
DISTRIBUTION ACCORDING TO BMI AND PP4TG 
 
W-H Ratio Normal  PP4TG High PP4TG Total 
Normal 6 2 8 
Overweight 16 24 40 
High 14 38 52 
Total 36 64 100 
 
 In the present study, out of 52 patients having high body mass 
index, 38 patients (73.07%) had high postprandial triglyceride levels. 
While out of 40 patients having Body Mass Index in overweight range 
24 patients had (60%) high postprandial triglyceride levels. And 2 
patients out of 8 patients (25%) having normal Body Mass Index had 
high PP4TG levels. (P value <0.05 by Chi-square method) 
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TABLE  - 12 
DISTRIBUTION ACCORDING TO PP4TG AND HDL 
 
PP4TG Normal  HDL Low HDL Total 
Normal 22 14 36 
High 20 44 64 
Total 42 58 100 
 
 In the present study, out of 100 patients 64 had postprandial 
hypertriglyceridemia. Out of 64, 44 had low fasting S. HDL and 20 
had normal fasting S. HDL. While 36 patients had normal postprandial 
S.Triglyceride level, out of 36, 14 had low fasting S.HDL and 22 had 
normal fasting S.HDL.  There is no relation found between HDL level 
and High PP4TG levels (P value is 0.34). 
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TABLE  - 13 
DISTRIBUTION ACCORDING TO DIABETES AND PP4TG 
 
Diabetes Normal  PP4TG High PP4TG Total 
Absent 23 9 32 
Present 13 55 68 
Total 36 64 100 
 
 In the present study, 64 patients had high postprandial 
S.triglyceride level, out of 64 patients 55 were diabetic. Only 9 
patients were not diabetic. In the remaining 36 patients who had 
normal postprandial S.triglyceride level, 13 were diabetic and 23 were 
non-diabetic. 
 
 There was strong association found between Diabetes Mellitus 
and High PP4TG levels. The calculated odd ratio is 10.8. 
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TABLE  - 14 
DISTRIBUTION ACCORDING TO HYPERTENSION AND 
PP4TG 
 
Hypertension Normal  PP4TG High PP4TG Total 
Absent 25 18 43 
Present 11 46 57 
Total 36 64 100 
 
 In the present study, 64 patients had high postprandial 
S.triglyceride level. Out of 64 patients 46 were hypertensive. Only 18 
patients were not hypertensive. In the remaining 36 patients who had 
normal postprandial S.triglyceride level, 11 were hypertensive and 25 
were non-hypertensive. There was an association found between 
Hypertension and High PP4TG level (P value < 0.05). 
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DISCUSSION 
 
AGE AND GENDER 
 In the present study, 69% patients were aged less than 55 years. 
While 75% female and 62% male were aged less than 55 years. These 
finding shows that middle age patients are more likely to be selected 
for study like the present study. (P value <0.05) 
 
 In Hiroyasu et al study, 55% were male and 45% were female, 
average age was 55.1 ± 6.3 years. In that study also majority of 
patients were from middle age group. (P value <0.05) 
 
OBESITY AND WAIST-HIP RATIO 
 In our study, 40% of patients were overweight, 52% of patients 
were obese, according to National Institutes of Health Definition. The 
mean BMI was 30.08. 
 
 The mean BMI in normal PP4TG group was 28.90 and high 
PP4TG group was 30.87, so there is strong correlation found between 
High BMI and High PP4TG. 
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 In Hiroyasu et al study, the mean BMI was 28.08. 
 
 The mean WHR in normal PP4TG group was 0.968 and high 
PP4TG group was 1.028, so there is strong correlation found between 
High WHR and High PP4TG. 
 
 In Couillard et al study, on postprandial triglyceride response in 
visceral obesity showed that obesity and waist hip ratio are associated 
with impaired postprandial TG clearance. 
 
DIABETES MELLITUS 
 In our study 64% were diabetic of which 62.5% of male were 
suffering from Diabetes Mellitus, whereas 68.18% females were 
diabetic. 
 
 The mean FBS in normal PP4TG group was 80.30 and high 
PP4TG group was 168.90, so there is strong correlation found between 
High FBS and High PP4TG. 
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 The mean PP2BS in normal PP4TG group was 174.30 and high 
PP4TG group was 226.46, so there is strong correlation found between 
High PP2BS and High PP4TG. 
 
 In Hiroyasu et al study, 52.1% patients were diabetic. A study 
done by Mette Axelsen et al, on postprandial Hypertriglyceridemia 
and type-2 diabetes showed postprandial lipid intolerance despite 
having normal fasting triglyceride level and increased risk of macro-
angiopathy. 
 
TRIGLYCERIDE 
 In this study, out of 100 patients, 64 patients showed serum 
triglyceride level more than 160mg% after 4 hour of meal. 34 out of 
56 male patients (60.7%) and 30 out of 44 females (68.18%) showed 
postprandial hypertriglyceridemia these data tells that patient having 
ischemic Heart disease, even if they have normal fasting triglyceride 
levels, they might have impaired postprandial lipid metabolism. 
 
 The mean PP4TG was 181.47mg% (P Value <0.05) suggest that 
there is an association between coronary artery disease and PP4TG 
levels and the relative risk was 1.75. 
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 In Hiroyasu et al study, 58% male and 64% female patients 
showed postprandial hypertriglyceridemia. (P value <0.05) 
 In Borge G. Nordestgaard et al study on Non fasting 
Triglycerides and risk of Myocardial infarction, Ischemic Heart 
disease and Death in Men and Women showed that non-fasting 
triglyceride levels independently predict myocardial infarction, 
ischemic heart disease and death. 
 
HYPERTENSION 
 In our study 57 patients were hypertension. 32 male patients 
(57.14%) were Hypertensive and 25 female (56.81%) were 
hypertensive. 
 
 The mean systolic blood pressure in normal PP4TG group was 
129.88, high PP4TG group was 141.84 and the mean diastolic blood 
pressure in normal PP4TG group was 84.16 and high PP4TG group 
was 88.51, so there is strong correlation found between hypertension 
and High PP4TG. 
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 In Kolovou et al study on postprandial Lipemia in Hypertension 
suggest that patient with hypertension have an exaggerated response 
and delayed clearance of plasma TGL concentration. 
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CONCLUSION 
 
 In our study with reference to patient of ischemic heart disease,    
postprandial Hypertriglyceridemia was found in 64% patients, having 
normal fasting triglyceride level. 
  
 There is statistically a significant correlation between 
postprandial triglyceride and ischemic heart disease, even in patients 
having normal fasting triglyceride level. It means that patients having 
high postprandial triglyceride levels have higher risk of Ischemic heart 
disease. The relative risk is 1.44. 
 
 There is statistically a significant correlation found between 
postprandial Hypertriglyceridemia and high waist-hip ratio and 
Diabetes Mellitus. 
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SUMMARY 
 
 In the study entitled “Postprandial Hypertriglyceridemia as a 
Independent Risk Factor for Ischemic Heart Disease” conducted at 
Govt. Mohan Kumaramangalm Medical College Hospital, Salem from 
July 2007 to June 2008, a total of 100 patients of ischemic Heart 
disease were included as per defined criteria. 
 
 Postprandial Hypertriglyceridemia was found in 64%, 52% had 
high BMI, 73% patients had High Waist Hip ratio and 64% patients 
had Diabetes Mellitus. Increased triglyceride level is a risk factor for 
cardiovascular disease independent of HDL cholesterol level. 
 
 Our study showed patients of ischemic Heart disease have high 
postprandial triglyceride levels inspite of normal fasting triglyceride 
level. There is a positive correlation between high waist-hip ratio, 
diabetes mellitus and postprandial hypertriglyceridemia in ischemic 
heart disease patients. 
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 Non fasting triglyceride levels indicate the presence of remnant 
lipoproteins, which may promote atherosclerosis. Postprandial 
Hypertriglyceridemia may be an independent risk factor for 
Atherosclerosis in Ischemic Heart Disease patients. 
 
 Evaluation of postprandial triglyceride levels is important 
during assessment of ischemic heart disease patients. 
 
FUTURE PROSPECTS 
 After establishment of postprandial lipemia as a better marker 
for atherosclerosis in large population group based prospective trial, 
we can, 
1. Design future trials of agents aimed at reducing triglyceride 
levels or attenuating atherogenic metabolic abnormalities. 
2. Study of morbidity and mortality in patients of ischemic 
heart disease between patients on treatment for control of 
postprandial lipemia with patients without treatment of 
postprandial lipemia. 
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PROFORMA 
 
Name:     Age:    Sex: 
Place:       Occupation:  
Hospital No:    Date of Admission: 
      Date of Discharge: 
 
CHIEF COMPLAINTS: 
 
 
PAST HISTORY: 
Diabetes: 
Hypertension: 
C.V.stroke: 
Dyslipidemia: 
 
PERSONAL HISTORY: 
Smoking: 
Alcohol 
Sedentary life style 
 2
FAMILY HISTORY: 
 
 
 
GENERAL PHYSICAL EXAMINATION: 
Pulse: 
Blood Pressure: 
Temperature: 
Locomotor Brachialis: 
Carotid Bruit: 
Cord like Artery: 
Height:       Waist: 
Weight:       Hip: 
Body mass index:     Waist hip ratio: 
 
CARDIOVASCULAR EXAMINATION: 
 
OTHER SYSTEMS: RESPIRATORY SYSTEM: 
    ABDOMEN:  
    CNS: 
 
 3
INVESTIGATIONS: 
 
 
Fasting blood sugar: 
Post prandial blood sugar: 
 
ELECTRO CARDIOGRAM: 
 ST DEPRESSION IN LEADS: 
 
S. CPK MB : 
 
FASTING  
 S. Cholesterol: 
 S. Triglyceride: 
 S.  HDL 
 S. LDL 
 S. VLDL 
 
POST - PRANDIAL TRIGLYCERIDE: 
 4
ABBREVIATIONS 
 
 
TGL  :  Triglycerides 
CAD  :  Coronary Artery Disease 
HDL  :  High density Lipoprotein 
LDL  :  Low density Lipoprotein 
VLDL :  Very Low density Lipoprotein 
ECG  :  Electro Cardiogram 
LPL  :  Lipoprotein Lipase 
M.I  :  Myocardial infarction 
S.CPK-MB :  Serum Creatinine phosphokinase – MB 
PP4 TG :  Postprandial Triglycerides 4hours after meal 
HW  :  Housewife 
DL  :  Daily Labour 
BM  :  Business Man 
PP2BS :  Postprandial Blood sugar 2hours after meal 
 
